BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kothari AN, Arffa ML, Chang V, Blackwell RH, Syn WK, Zhang J, Mi Z, Kuo PC. Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition. J Clin Med 2016;5:E39. [PMID: 27023622 DOI: 10.3390/jcm5040039] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Kariya Y, Kariya Y. Osteopontin in Cancer: Mechanisms and Therapeutic Targets. IJTM 2022;2:419-47. [DOI: 10.3390/ijtm2030033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pulford CS, Uppalapati CK, Montgomery MR, Averitte RL, Hull EE, Leyva KJ. A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues. IJMS 2022;23:9183. [DOI: 10.3390/ijms23169183] [Reference Citation Analysis]
3 Qin S, Yi L, Liang Y, Chen Y, Wang W, Liao Y, Zhang C, Huang H, Huang J, Yao S. Biological and Clinicopathological Characteristics of OPN in Cervical Cancers. Front Genet 2022;13:836509. [DOI: 10.3389/fgene.2022.836509] [Reference Citation Analysis]
4 Zeng P, Zhang X, Xiang T, Ling Z, Lin C, Diao H. Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers. Bioengineered 2022;13:3221-39. [DOI: 10.1080/21655979.2021.2020391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bhadresha K, Kumar SP, Brahmbhatt J, Patel C, Pandya P, Jain N, Rawal R. Theaflavin-3-gallate, a natural antagonist for Hsp90: In-silico and in-vitro approach. Chem Biol Interact 2021;:109774. [PMID: 34958756 DOI: 10.1016/j.cbi.2021.109774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pretzsch E, Lampert C, Bazhin AV, Link H, Jacob S, Guba M, Werner J, Neumann J, Angele MK, Bösch F. EMT-related genes are unlikely to be involved in extracapsular growth of lymph node metastases in gastric cancer. Pathol Res Pract 2021;229:153688. [PMID: 34872022 DOI: 10.1016/j.prp.2021.153688] [Reference Citation Analysis]
7 Zhou Y, Liu S, Liu C, Yang J, Lin Q, Zheng S, Chen C, Zhou Q, Chen R. Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor. Int J Biol Sci 2021;17:3760-75. [PMID: 34671197 DOI: 10.7150/ijbs.61717] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wang X, Yu Y, Ji L, Geng Z, Wang J, Liu C. Calcium phosphate-based materials regulate osteoclast-mediated osseointegration. Bioact Mater 2021;6:4517-30. [PMID: 34632163 DOI: 10.1016/j.bioactmat.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
9 Viana BPPB, Gomes AVP, Gimba ERP, Ferreira LB. Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms. Biomedicines 2021;9:1372. [PMID: 34680488 DOI: 10.3390/biomedicines9101372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Asif PJ, Longobardi C, Hahne M, Medema JP. The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis. Cancers (Basel) 2021;13:4720. [PMID: 34572947 DOI: 10.3390/cancers13184720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
11 Peralta S, Duhamel GE, Katt WP, Heikinheimo K, Miller AD, Ahmed F, McCleary-Wheeler AL, Grenier JK. Comparative transcriptional profiling of canine acanthomatous ameloblastoma and homology with human ameloblastoma. Sci Rep 2021;11:17792. [PMID: 34493785 DOI: 10.1038/s41598-021-97430-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zubareva EY, Senchukova MA. Prognostic and predictive significance of osteopontin in malignant neoplasms. Usp mol onkol 2021;8:23-8. [DOI: 10.17650/2313-805x-2021-8-2-23-28] [Reference Citation Analysis]
13 Amilca-Seba K, Sabbah M, Larsen AK, Denis JA. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers (Basel) 2021;13:3793. [PMID: 34359694 DOI: 10.3390/cancers13153793] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Sharma M, Hunter KD, Fonseca FP, Radhakrishnan R. Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformation. Head Neck 2021;43:3153-64. [PMID: 34227702 DOI: 10.1002/hed.26805] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Li J, Lan J, Qiao Q, Shen L, Lu G. Effluent Osteopontin levels reflect the peritoneal solute transport rate. Open Med (Wars) 2021;16:847-53. [PMID: 34141898 DOI: 10.1515/med-2021-0302] [Reference Citation Analysis]
16 Teuwen LA, De Rooij LPMH, Cuypers A, Rohlenova K, Dumas SJ, García-Caballero M, Meta E, Amersfoort J, Taverna F, Becker LM, Veiga N, Cantelmo AR, Geldhof V, Conchinha NV, Kalucka J, Treps L, Conradi LC, Khan S, Karakach TK, Soenen S, Vinckier S, Schoonjans L, Eelen G, Van Laere S, Dewerchin M, Dirix L, Mazzone M, Luo Y, Vermeulen P, Carmeliet P. Tumor vessel co-option probed by single-cell analysis. Cell Rep 2021;35:109253. [PMID: 34133923 DOI: 10.1016/j.celrep.2021.109253] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
17 Lin Z, Süsskind D. Evaluation of a Three-Marker Panel for the Detection of Uveal Melanoma Metastases: A Single-Center Retrospective Analysis. Cancers (Basel) 2021;13:2464. [PMID: 34070192 DOI: 10.3390/cancers13102464] [Reference Citation Analysis]
18 Hatipoglu OF, Uctepe E, Opoku G, Wake H, Ikemura K, Ohtsuki T, Inagaki J, Gunduz M, Gunduz E, Watanabe S, Nishinaka T, Takahashi H, Hirohata S. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition. Biomed Pharmacother 2021;139:111633. [PMID: 34243624 DOI: 10.1016/j.biopha.2021.111633] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Bellan M, Piccinino C, Tonello S, Minisini R, Giubertoni A, Sola D, Pedrazzoli R, Gagliardi I, Zecca E, Calzaducca E, Mazzoleni F, Piffero R, Patti G, Pirisi M, Sainaghi PP. Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs). Pharmaceuticals (Basel) 2021;14:394. [PMID: 33919476 DOI: 10.3390/ph14050394] [Reference Citation Analysis]
20 Fudalej MM, Badowska-Kozakiewicz AM. Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes. Oncol Lett 2021;21:417. [PMID: 33841578 DOI: 10.3892/ol.2021.12678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Perego S, Sansoni V, Ziemann E, Lombardi G. Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines. Int J Mol Sci 2021;22:2005. [PMID: 33670492 DOI: 10.3390/ijms22042005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Bartosińska J, Przepiórka-Kosińska J, Sarecka-Hujar B, Raczkiewicz D, Kowal M, Chyl-Surdacka K, Bartosiński J, Kosiński J, Krasowska D, Chodorowska G. Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients. J Clin Med 2021;10:755. [PMID: 33668559 DOI: 10.3390/jcm10040755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hughes AM, Kolb AD, Shupp AB, Shine KM, Bussard KM. Printing the Pathway Forward in Bone Metastatic Cancer Research: Applications of 3D Engineered Models and Bioprinted Scaffolds to Recapitulate the Bone-Tumor Niche. Cancers (Basel) 2021;13:507. [PMID: 33572757 DOI: 10.3390/cancers13030507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Meškytė EM, Keskas S, Ciribilli Y. MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. Int J Mol Sci 2020;21:E7710. [PMID: 33081056 DOI: 10.3390/ijms21207710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
25 Riquelme MA, Cardenas ER, Jiang JX. Osteocytes and Bone Metastasis. Front Endocrinol (Lausanne) 2020;11:567844. [PMID: 33162934 DOI: 10.3389/fendo.2020.567844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
26 Yamane M, Sato S, Shimizu E, Shibata S, Hayano M, Yaguchi T, Kamijuku H, Ogawa M, Suzuki T, Mukai S, Shimmura S, Okano H, Takeuchi T, Kawakami Y, Ogawa Y, Tsubota K. Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans. FASEB J 2020;34:10778-800. [PMID: 32619061 DOI: 10.1096/fj.201900218R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
27 Yang X, Chen S, Liu X, Yu M, Liu X. Drug Delivery Based on Nanotechnology for Target Bone Disease. Curr Drug Deliv 2019;16:782-92. [PMID: 31530265 DOI: 10.2174/1567201816666190917123948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Wang W, Wang S, Zhang M. Evaluation of kininogen 1, osteopontin and α-1-antitrypsin in plasma, bronchoalveolar lavage fluid and urine for lung squamous cell carcinoma diagnosis. Oncol Lett 2020;19:2785-92. [PMID: 32218831 DOI: 10.3892/ol.2020.11376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Si J, Wang C, Zhang D, Wang B, Zhou Y. Osteopontin in Bone Metabolism and Bone Diseases. Med Sci Monit 2020;26:e919159. [PMID: 31996665 DOI: 10.12659/MSM.919159] [Cited by in Crossref: 13] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
30 Jin W. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition. Cells 2020;9:E217. [PMID: 31952344 DOI: 10.3390/cells9010217] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 60.0] [Reference Citation Analysis]
31 Mirzaei H, Khodadad N, Karami C, Pirmoradi R, Khanizadeh S. The AP-1 pathway; A key regulator of cellular transformation modulated by oncogenic viruses. Rev Med Virol 2020;30:e2088. [PMID: 31788897 DOI: 10.1002/rmv.2088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Huang J, Chang S, Lu Y, Wang J, Si Y, Zhang L, Cheng S, Jiang WG. Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells. Cancer Cell Int 2019;19:306. [PMID: 31832019 DOI: 10.1186/s12935-019-1033-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
33 Alam M, Bertolini M, Gherardini J, Keren A, Ponce L, Chéret J, Alenfall J, Dunér P, Nilsson AH, Gilhar A, Paus R. An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytes. Br J Dermatol 2020;182:1404-14. [PMID: 31487385 DOI: 10.1111/bjd.18479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Lamort AS, Giopanou I, Psallidas I, Stathopoulos GT. Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight. Cells 2019;8:E815. [PMID: 31382483 DOI: 10.3390/cells8080815] [Cited by in Crossref: 27] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
35 Kolb AD, Bussard KM. The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases. Cancers (Basel) 2019;11:E1020. [PMID: 31330786 DOI: 10.3390/cancers11071020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
36 Scott LE, Weinberg SH, Lemmon CA. Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition. Front Cell Dev Biol. 2019;7:135. [PMID: 31380370 DOI: 10.3389/fcell.2019.00135] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
37 Elkhidir Y, Lai R, Feng Z. The impact of photofunctionalized gold nanoparticles on osseointegration. Heliyon 2018;4:e00662. [PMID: 30094359 DOI: 10.1016/j.heliyon.2018.e00662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Khaliullin TO, Kisin ER, Murray AR, Yanamala N, Shurin MR, Gutkin DW, Fatkhutdinova LM, Kagan VE, Shvedova AA. Mediation of the single-walled carbon nanotubes induced pulmonary fibrogenic response by osteopontin and TGF-β1. Exp Lung Res 2017;43:311-26. [PMID: 29140132 DOI: 10.1080/01902148.2017.1377783] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
39 Ramadan A, Afifi N, Yassin NZ, Abdel-Rahman RF, Abd El-Rahman SS, Fayed HM. Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. Chem Biol Interact 2018;289:109-18. [PMID: 29738702 DOI: 10.1016/j.cbi.2018.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
40 LaGrandeur RG, Singhal M, Bany-Mohammed F, Uy C, Koeppel R, Zaldivar F, Haddad F, Nalbandian A, Donovan P, Cooper DM, Aslam M. Pilot feasibility study to detect mesenchymal stem cell biomarkers of bronchopulmonary dysplasia in the tracheal aspirate fluid of preterm infants. J Neonatal Perinatal Med 2018;11:1-10. [PMID: 29689740 DOI: 10.3233/NPM-181722] [Reference Citation Analysis]
41 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 120] [Article Influence: 23.5] [Reference Citation Analysis]
42 Aznar N, Ear J, Dunkel Y, Sun N, Satterfield K, He F, Kalogriopoulos NA, Lopez-Sanchez I, Ghassemian M, Sahoo D, Kufareva I, Ghosh P. Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple. Sci Signal 2018;11:eaao4220. [PMID: 29487190 DOI: 10.1126/scisignal.aao4220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
43 Marques DS, Grativol J, Alves da Silva Peres R, da Rocha Matos A, Gimba ERP. Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines. Tumour Biol 2017;39:1010428317725442. [PMID: 28936921 DOI: 10.1177/1010428317725442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
44 Aznar N, Sun N, Dunkel Y, Ear J, Buschman MD, Ghosh P. A Daple-Akt feed-forward loop enhances noncanonical Wnt signals by compartmentalizing β-catenin. Mol Biol Cell 2017;28:3709-23. [PMID: 29021338 DOI: 10.1091/mbc.E17-06-0405] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
45 Choi SI, Kim SY, Lee JH, Kim JY, Cho EW, Kim IG. Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells. Oncotarget 2017;8:101284-97. [PMID: 29254164 DOI: 10.18632/oncotarget.21021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
46 Möbius P, Preidl RHM, Weber M, Amann K, Neukam FW, Wehrhan F. Re-expression of pro-fibrotic, embryonic preserved mediators in irradiated arterial vessels of the head and neck region. Strahlenther Onkol 2017;193:951-60. [DOI: 10.1007/s00066-017-1192-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
47 Ishigamori R, Komiya M, Takasu S, Mutoh M, Imai T, Takahashi M. Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice. Int J Mol Sci 2017;18:E1058. [PMID: 28505114 DOI: 10.3390/ijms18051058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
48 Ito M, Makino N, Matsuda A, Ikeda Y, Kakizaki Y, Saito Y, Ueno Y, Kawata S. High Glucose Accelerates Cell Proliferation and Increases the Secretion and mRNA Expression of Osteopontin in Human Pancreatic Duct Epithelial Cells. Int J Mol Sci 2017;18:E807. [PMID: 28417915 DOI: 10.3390/ijms18040807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
49 Konstantakou EG, Velentzas AD, Anagnostopoulos AK, Litou ZI, Konstandi OA, Giannopoulou AF, Anastasiadou E, Voutsinas GE, Tsangaris GT, Stravopodis DJ. Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets. PLoS One 2017;12:e0171512. [PMID: 28158294 DOI: 10.1371/journal.pone.0171512] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
50 De Fusco C, Messina A, Monda V, Viggiano E, Moscatelli F, Valenzano A, Esposito T, Sergio C, Cibelli G, Monda M, Messina G. Osteopontin: Relation between Adipose Tissue and Bone Homeostasis. Stem Cells Int 2017;2017:4045238. [PMID: 28194185 DOI: 10.1155/2017/4045238] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
51 Guldbrandsen A, Farag Y, Kroksveen AC, Oveland E, Lereim RR, Opsahl JA, Myhr KM, Berven FS, Barsnes H. CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders. Mol Cell Proteomics 2017;16:300-9. [PMID: 27890865 DOI: 10.1074/mcp.O116.064477] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
52 Khan Z, Marshall JF. The role of integrins in TGFβ activation in the tumour stroma. Cell Tissue Res 2016;365:657-73. [PMID: 27515461 DOI: 10.1007/s00441-016-2474-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
53 Melve GK, Ersvaer E, Akkök ÇA, Ahmed AB, Kristoffersen EK, Hervig T, Bruserud Ø. Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor. Int J Mol Sci 2016;17:E1158. [PMID: 27447610 DOI: 10.3390/ijms17071158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Duarte-Salles T, Misra S, Stepien M, Plymoth A, Muller D, Overvad K, Olsen A, Tjønneland A, Baglietto L, Severi G, Boutron-Ruault MC, Turzanski-Fortner R, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Bamia C, Pala V, Palli D, Mattiello A, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Quirós JR, Agudo A, Sánchez-Cantalejo E, Ardanaz E, Gavrila D, Dorronsoro M, Werner M, Hemmingsson O, Ohlsson B, Sjöberg K, Wareham NJ, Khaw KT, Bradbury KE, Gunter MJ, Cross AJ, Riboli E, Jenab M, Hainaut P, Beretta L. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Cancer Prev Res (Phila) 2016;9:758-65. [PMID: 27339170 DOI: 10.1158/1940-6207.CAPR-15-0434] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]